MYGN vs XLU
Myriad Genetics Inc (MYGN) versus XLU (XLU) — a side-by-side from cached financials, not a winner call.
Myriad Genetics Inc (MYGN) is a diagnostics & research company listed on NASDAQ.
XLU (XLU) common stock.
Latest reported MYGN revenue for 2024-12-31 was $837.6M. Net income was -$127.3M. Revenue was up 11.2% from 2023-12-31 to 2024-12-31. MYGN currently screens at market cap $413.7M.
XLU does not have a complete income-statement cache yet.
MYGN currently screens at market cap $413.7M. XLU currently screens at market cap $0.
Not investment advice. Open the MYGN and XLU stock pages for the full models.
Not investment advice.